Quarterly report pursuant to Section 13 or 15(d)

NOTE 6: MARKETABLE SECURITIES

v3.19.1
NOTE 6: MARKETABLE SECURITIES
3 Months Ended
Mar. 31, 2019
Notes  
NOTE 6: MARKETABLE SECURITIES

NOTE 6: MARKETABLE SECURITIES

 

The Company utilizes FAS 115 “Accounting for Certain Investments in Debt and Equity Securities”. The Company received marketable securities, 10,300,000 fully paid ordinary unrestricted shares in Impression Healthcare Limited (Australian Company), traded on Australian Security Exchange by the code IHL as part of the agreement and letter of intent (LOI). The Company categorize these securities as trading securities and report them at fair value, with unrealized gains and losses included in earnings. The Company recorded securities at FMV at the price of A$0.02 per share and exchange rate of $0.74 AUD/USD valued $150,000. On March 29, 2019 the stock price was A$ 0.024 per share as quoted on www.asx.com.au and exchange rate of $0.71 AUD/USD as quoted on www.oanda.com and had FMV $175,000 as of March 31, 2019. The change to the FMV in marketable securities for the period resulted in unrealized gain of $25,000 which Company recorded on March 31, 2019.